Modern approaches to functional dyspepsia treatment
Abstract
The aim of review. To present modern approach to treatment of functional dyspepsia (FD).
Key points. Treatment of FD should be comprehensive and include general recommendations, application of drugs and psychotherapeutic methods. At a choice of specific drug clinical variant of disease should be taken into account. At pain-predominant (ulcer-like) variant antisecretory agents (first of all — proton pump inhibitors) are the drugs of choice, at postprandial distress syndrome (dysmotility-like variant) - prokinetics. In resistant cases psychotropic drugs and psychotherapeutic methods are indicated.
Conclusion. Investigation of FD pathogenesis should be continued that will provide more differentiated treatment approach and improve the results.
About the Author
A. A. Sheptulin
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university». Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Sheptulin Arkady A — MD, PhD, professor, Chair of internal diseases propedeutics, medical faculty
119991, Moscow, Pogodinskaya street, 1, bld 1
References
1. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией. Фарматека 2009; 13:50-4.
2. Ивашкин В.Т., Шептулин А.А., Киприанис В.А. Функциональная диспепсия. М., МЕДпресс, 2011.
3. Картавенко И.М. Морфофункциональная оценка двенадцатиперстной кишки у лиц с функциональной диспепсией: Автореф. дис. ... канд. мед. наук. М., 2008:23 с.
4. Охлобыстина О.З. Некоторые особенности патогенеза, клиники, диагностики и лечения синдрома функциональной диспепсии: Автореф. дис. ... канд. мед. наук. М., 2007:24 с.
5. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Рос журн гастроэнтерол гепатол колопроктол 2012; 22(1):87-91.
6. Allescher H.-D., Böckenhoff A., Knapp G., et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36:934-41.
7. Altan E., Masaoka T., Farre R., Tack J. Acotiamide, a novel gastroprokinetiс for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol 2012; 6:533-44.
8. Von Armin U., Peitz U., Vinson B., et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Amer J Gastroenterol 2007; 112:1268-75.
9. Bates S., Sjoden P.-O., Nyren O. Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988; 17:15565.
10. Braak B., Klooker T., Lei A., et al. Effect of amitriptiyline on drinking capacity and symptoms in patients with functional dyspepsia. DDW – New Orleans, 2010. Abstract 1067.
11. Braden B., Caspary W., Börner N., et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptiyng in patients with functional dyspepsia and gastroparesis . Neurogastroenterol. Motil. 2009; 21:632-5.
12. Calvert E., Houghton L., Cooper P., et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002; 123:1778-85.
13. Camilleri M., Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10:187-94.
14. Сonnoly M.P., Bhatt A., Simmonds R. Implementing UK National dyspepsia guidelines for returning patients to self-care: findings from an educational intervention and 12-month follow-up clinical re-audit. Gut 2009; 58 (suppl. 58). Abstract P0129.
15. Futagami S., Shimpuku M., Song J.M., et al. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying. Digestion 2012; 86:114-21.
16. Hamilton J., Guthrie E., Creed F., et al. A randomised controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000; 119:661-9.
17. Haug T.T., Wilhelmsen I., Sveback S., et al. Psychotherapy in functional dyspepsia. J Psychosomat Res 1994; 38:735-44.
18. Holtmann G., Talley N.J., Liebregts T., et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354:832-40.
19. Holtmann G., Nandurkar S. Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systemic review of the literature and meta-analysis. Gastroenterology. 2007; 132 (4) Suppl. 2 (Abstract W1204)
20. Huang X., Lv B., Zhang S., et al. Itopride therapy for functional dyspepsia: a meta-analysis World J Gastroenterol 2012; 18:7371-7.
21. Jackson J.L., O’Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108:65-72.
22. Kamiya T., Shikano M., Mizushima T., et al. Comparison of rabeprazole and itopride in the treatment of functional dyspepsia sub-analysis: Nagoya multicentre randomised comparative trial. DDW – New Orleans, 2010. Abstract T1095.
23. Karamanolis G., Tack J. Promotility medications – now and in the future. Dig Dis 2006; 24:297-307.
24. Kinoshita Y., Chiba T. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroupe analysis from FUTURE study. J Gastroenterol 2012; 47:377-86.
25. Lan L., Yu J., Chen Y.L. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol 2011; 17:3242-7.
26. Madisch A., Melderis H., Mayr G. et al. Ein Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie. Z.Gastroenterologie 2001; 39:1-8
27. Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:2719.
28. Malfertheiner P., Megraud F., O’Morain C., et al. Management of Helicobacter pylori infection – the Maastricht IV Florens Consensus Report. Gut 2012; 61:646-64.
29. Matsueda K. Hongo M., Tack J., et al. A placebocontrolled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61:821-8.
30. Mazzoleni L.E., Sander G.B., Francesconi C.F., et al. Helicobacter pylori eradication in functional dyspepsia: HERDES trial. Arch Intern Med 2011; 28:1929-36.
31. McQuaid K.R. Dyspepsia. In: Sleisenger and Fordtran’s gastrointestinal and liver disease / Eds. M. Feldman et al. 7 t h ed. Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002:102-18.
32. Miwa H., Nagahara A. Symptomatic response pattern to PPI in FD/NERD patients is not so simple – when should we change the treatment option? DDW – New Orleans, 2010. Abstract T1016.
33. Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2012; 28:602-7.
34. Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127:1329-37.
35. Moayyedi P., Soo S., Deeks J., et al. Systemic review: Antacids, H 2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003; 17:1215-27.
36. Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia. World J Gastroenterol 2006; 12:2694-700.
37. Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast) – a safe and effective standart in the treatment of functional gastrointestinal disorders. Wiem Med Wochenschr 2012. DOI 10. 1007/ s10354-012-0160-x.
38. Patel A., Kushnir V., Sayuk G.S. The impact of gastric emptying studies in the management of functional dyspepsia. DDW – New Orleans, 2010. Abstract W1399.
39. Rösch W., Vinson B., Sassin I. A randomized clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z.Gastroenterol. 2002; 40:401-8.
40. Sakaguchi M., Takao M., Ohyama Y. Comparison on PPIs and H 2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 2012; 18:1517-24.
41. Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for non-ulcer dyspepsia. Am J Gastroenterol 2004; 99:1817-22.
42. Tack J, Janssen P., Masaoka T., et al. Efficacy of buspirone, a fundus-relaxing dtug in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10:1239-45.
43. Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:146679.
44. Talley N.J., Herrick L., Locke G.R. Antidepressants in functional dyspepsia. Exp Rev Gastroenterol Hepatol 2010; 4:5-8.
45. Tan V.P., Cheung T.K., Wong W.M., et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012; 18:127-33.
46. Tominaga K., Suzuki H., Umegaki E., et al. Rabeprazole improves the symptoms of functional dyspepsia – a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study. DDW – New Orleans, 2010. Abstract 383.
47. Van Kerkhoven L.F., Laheij R.J., Aparico N. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008; 6:746-52.
48. Veldhuyzen van Zanten S.J., Chiba N., Armstrong D., et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADETHN study. Am J Gastroenterol 2005; 2005:1477-89.
49. Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., Talley N.J. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastoenterol 2001; 96:689-96.
50. Wu C., Chou L., Chen H., et al. Effect of fluoxetine on symptoms, sleep and visceral perception in patients with functional dyspepsia. Hepatogastroenterology 2003; 50:278-83.
Review
For citations:
Sheptulin A.A. Modern approaches to functional dyspepsia treatment. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(6):13-20. (In Russ.)
Views:
111
Email this article 
